NanoHive Medical announced the award of a Federal Supply Schedule Contract by the US Department of Veteran Affairs (VA). The contract grants access to the Veteran’s Health Administration (VHA) for the company’s complete line of 3D printed Hive™ interbody devices that feature proprietary Soft Titanium® technology. The VA is the largest healthcare system in the United States, that serves over 9 million enrolled veterans, 6.1 million of which receive healthcare at over 150 hospitals in the US. There are 400,000 medical and surgical discharges annually at these facilities.
With the recent launch of the Hive™ Standalone Cervical System, along with the Hive™ Standalone Anterior Lumbar System, the company is positioned as the leader of 3D printed titanium anterior stand-alone fusion systems. Patrick O’Donnell, President & CEO of NanoHive Medical remarks, “We are excited about the approval on the Federal Supply Schedule Contract and very proud to provide our unique technology to the VA System and our country’s veterans.”
RELATED: NDI Launches Polaris Lyra® Next-Generation Compact Optical Tracker
NanoHive Medical currently distributes their products through a network of independent distributors as well as two strategic partners, Accelus and Precision Spine, Inc.
NanoHive Medical, LLC is a pioneer and leading innovator in 3D printed spinal interbody fusion implants and instrumentation. The company’s proprietary, biomimetic Soft Titanium® technology clearly distinguishes their products in the $1.9B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provide surgeons and their patients ideal biomechanical elastic modulus properties, clear and precise diagnostic imaging capability, osteoblast cell attraction and integration – all features that lead to consistently strong fusion constructs and efficacious clinical experiences.
NanoHive Medical, LLC is a pioneer and leading innovator in 3D printed spinal interbody fusion implants and instrumentation. The company’s proprietary, biomimetic Soft Titanium® technology clearly distinguishes their products in the $1.9B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provide surgeons and their patients ideal biomechanical elastic modulus properties, clear and precise diagnostic imaging capability, osteoblast cell attraction and integration – all features that lead to consistently strong fusion constructs and efficacious clinical experiences.
NanoHive Medical is located in Woburn, Massachusetts U.S.A.
Contact: Patrick O’Donnell, CEO & President at Patrick.odonnell@nanohive.com
Website: www.nanohive.com
